Skip to content

Clinical trials

Phase 3 Non-alcoholic Fatty Liver Disease trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 3 Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20151
20161
20174
20191
20212
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Terminated5
Active, not recruiting4
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Akero Therapeutics, Inc2
Gilead Sciences2
Intercept Pharmaceuticals2
Eli Lilly and Company1
Genfit1
Inventiva Pharma1
King's College London1
Madrigal Pharmaceuticals, Inc.1
Newcastle-upon-Tyne Hospitals NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease17
Fibrosis5
Fatty Liver3
Liver Diseases3
Digestive System Diseases2
Liver Cirrhosis2
Metabolic Diseases2
Fatty Liver, Alcoholic1
Hepatic Encephalopathy1
Hepatic Insufficiency1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.